APA (7th ed.) Citation

Kuo, C., Lai, W., Lee, T., & Yang, C. (2025). Successful Treatment of Osimertinib Resistance in an EGFR‐Mutant Lung Cancer Patient With a Rare STRN3‐ALK Fusion Using Brigatinib and Osimertinib. Wiley.

Chicago Style (17th ed.) Citation

Kuo, Chia‐Yu, Wei‐An Lai, Tai‐Huang Lee, and Chih‐Jen Yang. Successful Treatment of Osimertinib Resistance in an EGFR‐Mutant Lung Cancer Patient With a Rare STRN3‐ALK Fusion Using Brigatinib and Osimertinib. Wiley, 2025.

MLA (9th ed.) Citation

Kuo, Chia‐Yu, et al. Successful Treatment of Osimertinib Resistance in an EGFR‐Mutant Lung Cancer Patient With a Rare STRN3‐ALK Fusion Using Brigatinib and Osimertinib. Wiley, 2025.